Package: DoseFinding Type: Package Title: Planning and Analyzing Dose Finding Experiments Version: 1.4-2.9000 Date: 2026-10-14 Authors@R: c( person("Bjoern", "Bornkamp", email = "bjoern.bornkamp@novartis.com", comment = c(ORCID = "0000-0002-6294-8185"), role = c("aut")), person("Jose", "Pinheiro", role = "aut"), person("Frank", "Bretz", role = "aut"), person("Ludger", "Sandig", role = "aut"), person("Marius", "Thomas", role = c("aut", "cre"), email = "marius.thomas@novartis.com"), person("Daniel", "Sabanes Bove", role = "aut", email = "daniel.sabanes_bove@rconis.com", comment = c(ORCID = "0000-0002-0176-9239")), person("Carina", "Miller", role = "ctb"), person(given = "Novartis Pharma AG", role = c("cph", "fnd"))) Imports: ggplot2, lattice, mvtnorm, Rdpack Suggests: emmeans, numDeriv, Rsolnp, quadprog, parallel, mmrm, multcomp, knitr, rmarkdown, MASS, testthat (>= 3.0.0), tibble, RBesT, nlme, survival, dplyr, tidyr Maintainer: Marius Thomas Description: The DoseFinding package provides functions for the design and analysis of dose-finding experiments (with focus on pharmaceutical Phase II clinical trials). It provides functions for: multiple contrast tests, fitting non-linear dose-response models (using Bayesian and non-Bayesian estimation), calculating optimal designs and an implementation of the MCPMod methodology (Pinheiro et al. (2014) ). VignetteBuilder: knitr License: GPL-3 LazyLoad: yes RoxygenNote: 7.3.2 Encoding: UTF-8 URL: https://github.com/openpharma/DoseFinding, https://openpharma.github.io/DoseFinding/ BugReports: https://github.com/openpharma/DoseFinding/issues Roxygen: list(markdown = TRUE) Config/testthat/edition: 3 RdMacros: Rdpack Repository: https://openpharma.r-universe.dev Date/Publication: 2026-10-16 14:36:25 UTC RemoteUrl: https://github.com/openpharma/DoseFinding RemoteRef: HEAD RemoteSha: c2788e69579dbfd85ddfa2d5e8030101ebd07e15 NeedsCompilation: yes Packaged: 2026-10-16 17:48:06 UTC; root Author: Bjoern Bornkamp [aut] (ORCID: ), Jose Pinheiro [aut], Frank Bretz [aut], Ludger Sandig [aut], Marius Thomas [aut, cre], Daniel Sabanes Bove [aut] (ORCID: ), Carina Miller [ctb], Novartis Pharma AG [cph, fnd]